Climb Bio, Inc. (CLYM)
7.25
+0.07
(+0.97%)
USD |
NASDAQ |
Mar 09, 16:00
7.35
+0.10
(+1.38%)
Pre-Market: 08:58
Climb Bio EPS Diluted (Quarterly) : -0.26 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Fortress Biotech, Inc. | 0.111 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Lyell Immunopharma, Inc. | -2.126 |
| PepGen Inc. | -0.2666 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.52M |
| Total Expenses (Quarterly) | 17.52M |
| Enterprise Value | 245.78M |
| Earnings Yield | -12.22% |
| Normalized Earnings Yield | -12.22 |